GH1 and central nervous system neoplasm: The safety of treatment with hGH has been investigated in numerous reports pertaining childhood cancer and CNS tumor survivors, with reassuring data regarding the use at substitutive doses in children with proven GH deficiency who have not attained final height and after they achieve disease remission.